Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP826464.RA97apXutkVhvnBPzpzGihLlbnCBI7eB3Sa2DfYeMQ-18130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP826464.RA97apXutkVhvnBPzpzGihLlbnCBI7eB3Sa2DfYeMQ-18130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP826464.RA97apXutkVhvnBPzpzGihLlbnCBI7eB3Sa2DfYeMQ-18130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP826464.RA97apXutkVhvnBPzpzGihLlbnCBI7eB3Sa2DfYeMQ-18130_provenance.
- NP826464.RA97apXutkVhvnBPzpzGihLlbnCBI7eB3Sa2DfYeMQ-18130_assertion description "[GRB7 protein over-expression was associated with negative estrogen and progesterone receptor status, higher tumor grade, larger primary tumor size, (more) axillary lymph node involvement, higher clinical stage, and shortened breast cancer-free interval.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP826464.RA97apXutkVhvnBPzpzGihLlbnCBI7eB3Sa2DfYeMQ-18130_provenance.
- NP826464.RA97apXutkVhvnBPzpzGihLlbnCBI7eB3Sa2DfYeMQ-18130_assertion evidence source_evidence_literature NP826464.RA97apXutkVhvnBPzpzGihLlbnCBI7eB3Sa2DfYeMQ-18130_provenance.
- NP826464.RA97apXutkVhvnBPzpzGihLlbnCBI7eB3Sa2DfYeMQ-18130_assertion SIO_000772 20635137 NP826464.RA97apXutkVhvnBPzpzGihLlbnCBI7eB3Sa2DfYeMQ-18130_provenance.
- NP826464.RA97apXutkVhvnBPzpzGihLlbnCBI7eB3Sa2DfYeMQ-18130_assertion wasDerivedFrom befree-2016 NP826464.RA97apXutkVhvnBPzpzGihLlbnCBI7eB3Sa2DfYeMQ-18130_provenance.
- NP826464.RA97apXutkVhvnBPzpzGihLlbnCBI7eB3Sa2DfYeMQ-18130_assertion wasGeneratedBy ECO_0000203 NP826464.RA97apXutkVhvnBPzpzGihLlbnCBI7eB3Sa2DfYeMQ-18130_provenance.
- befree-2016 importedOn "2016-02-19" NP826464.RA97apXutkVhvnBPzpzGihLlbnCBI7eB3Sa2DfYeMQ-18130_provenance.